Filter
5357
Filtered Results: 5357
Text search:
WHO-AIMS
Featured
Recommendations
461
New Publications
1394
Language
Document type
No document type
2929
Studies & Reports
888
Guidelines
611
Manuals
312
Strategic & Response Plan
240
Fact sheets
118
Training Material
115
Online Courses
53
Situation Updates
48
Resource Platforms
25
Infographics
9
Brochures
8
Videos
1
Countries / Regions
Global
255
India
218
Kenya
196
South Africa
128
Western and Central Europe
126
Ethiopia
125
Myanmar / Burma
112
Uganda
101
Nepal
99
Syria
95
Zambia
84
Nigeria
83
Sierra Leone
82
Malawi
82
Bangladesh
79
Tanzania
76
Liberia
75
Africa
69
Ghana
66
Rwanda
64
Ukraine
63
Latin America and the Carribbean
57
Philippines
55
Congo, Democratic Republic of
48
South Sudan
45
West and Central Africa
41
Indonesia
39
East and Southern Africa
36
Middle East and North Africa
35
Mozambique
34
Zimbabwe
33
Namibia
32
Asia
32
Lesotho
30
South–East Asia Region
30
Botswana
29
Eastern Europe
29
Yemen
28
Guinea
27
Cambodia
27
Senegal
26
Germany
26
Russia
26
Eastern Europe and Central Asia
24
Venezuela
23
Pakistan
22
Jordan
21
Lebanon
21
Burkina Faso
19
Haiti
19
Somalia
17
Afghanistan
17
Sudan
17
Brazil
17
Iraq
16
Central African Republic
16
Colombia
15
Vietnam
14
Cameroon
13
Western Pacific Region
13
Mali
12
Benin
12
Laos
12
Thailand
11
China
11
Eswatini/ Swaziland
11
Turkey
9
Egypt
8
Peru
8
Moldova
8
Côte d’Ivoire / Ivory Coast
7
Angola
7
Poland
7
Palestine
7
Tajikistan
7
Georgia
7
Niger
6
Libya
6
Sri Lanka
6
Chile
6
Iran
6
North America
6
USA
5
Italy
5
Albania
5
Romania
5
Tunisia
5
Singapore
4
Papua New Guinea
4
Serbia
4
Hungary
4
Burundi
4
Ecuador
4
Greece
4
Paraguay
4
Southern Africa
4
Timor Leste/ East Timor
4
Kyrgyzstan
4
Kazakhstan
4
Turkmenistan
4
United Kingdom
4
Guinea-Bissau
3
Morocco
3
Saudi Arabia
3
Gambia
3
Malaysia
3
Bolivia
3
Madagascar
3
Mexico
3
Fiji
3
Bhutan
3
Japan
3
Mauritius
3
Portugal
3
Israel
3
Togo
2
Chad
2
Argentina
2
North Macedonia
2
Croatia
2
Guatemala
2
Djibouti
2
Mongolia
2
Qatar
2
Lithuania
2
Slovakia
2
Gabon
2
Jamaica
2
Spain
2
Belarus
2
Mauritania
1
Ireland
1
Vanuatu
1
Honduras
1
El Salvador
1
Armenia
1
Canada
1
Bulgaria
1
Estonia
1
Uzbekistan
1
Denmark
1
Belgium
1
Maldives
1
Morocco
1
Azerbaijan
1
Bosnia and Herzegovina
1
Authors & Publishers
Publication Years
Category
Countries
2004
Public Health
332
Clinical Guidelines
309
Key Resources
296
Women & Child Health
277
Capacity Building
156
Pharmacy & Technologies
42
Annual Report MEDBOX
1
Toolboxes
Mental Health
472
COVID-19
442
HIV
324
Disability
254
Planetary Health
224
TB
223
Conflict
212
AMR
163
Rapid Response
141
Caregiver
140
Refugee
130
Global Health Education
127
Ebola
122
NCDs
111
NTDs
108
Natural Hazards
87
Pharmacy
84
Health Financing Toolbox
46
Specific Hazards
35
Cholera
31
Polio
31
Social Ethics
31
Zika
22
Typhoon
2
Health Financing
2
South Sudan
1
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Module 3
Counsellors
July 2017
Module 3: Counsellors. This module is for staff who counsel people as they consider PrEP or start taking PrEP and support them in coping with side-effects and adherence strategies. Those ... counsel PrEP users may be lay, peer or professional counsellors and healthcare workers, including nurses, clinical officers and doctors.
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
Module 8
Site Planning
July 2017
Module 8: Site planning. This module is for people involved in organizing PrEP services at specific sites. It outlines the steps to be taken in planning a PrEP service and gives suggestions for personnel, infrastructure and commodities that could be considered...
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reac...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals be...
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults ... are at substantial risk for HIV. It provides information on: factors that influence HIV susceptibility among young people; clinical considerations for safety and continuation on PrEP; ways to improve access and service utilization; and inclusive monitoring approaches to improve the recording and reporting of data on young people.
Module 1q
PrEP users
July 2017
Module 11: PrEP users. This module provides information for people who are interested in taking PrEP to reduce their risk of acquiring HIV and people who are al...
Revised Version 2011
Health care-associated infection (HCAI) places a serious disease burden and has a significant economic impact on patients and health-care systems throughout the world. Yet good hand hygiene, the simple task of cleaning hands at the right times and in the right way, can save lives. World Health O...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up in...
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care...
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interven...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A ... living guideline contains new information and a recommendation on hydroxychloroquine. It follows the publication of six trials synthesized in a living network meta-analysis (NMA).
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,...
